TrialPloS one2024

High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: A prospective non-randomized trial.

Xiyue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.